The challenge of antiretroviral-drug-resistant HIV: Is there any possible clinical advantage?

Current HIV Research

Volumn 2, Issue 3, 2004, Pages 283-292

  Zaccarelli, Mauro ^a   Tozzi, Valerio ^a   Perno, Carlo Federico ^a   Antinori, Andrea ^a  

^a NATIONAL INSTITUTE FOR INFECTIOUS DISEASES L SPALLANZANI   (Italy)

Author keywords

Fitness; Genotypic resistance test; HIV; HIV resistance; Hypersusceptibility; M184V mutation

Indexed keywords

ABACAVIR; ADEFOVIR; AMPRENAVIR; ANTIRETROVIRUS AGENT; ATAZANAVIR; DIDANOSINE; EFAVIRENZ; INDINAVIR; LAMIVUDINE; LOPINAVIR; METHIONINE; NEVIRAPINE; PROTEINASE INHIBITOR; RITONAVIR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR; STAVUDINE; TENOFOVIR; VALINE; VIRUS ENZYME; ZALCITABINE; ZIDOVUDINE;

CLINICAL TRIAL; DEATH; DISEASE COURSE; DRUG SENSITIVITY; FEMALE; GENE MUTATION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; IN VITRO STUDY; INFANT; NONHUMAN; PHENOTYPE; REVIEW; TREATMENT FAILURE; VIRUS MUTATION; VIRUS REPLICATION; WILD TYPE;

BIOLOGICAL MARKERS; CD4 LYMPHOCYTE COUNT; CLINICAL TRIALS; DRUG RESISTANCE, VIRAL; DRUG THERAPY, COMBINATION; HIV; HIV INFECTIONS; HIV PROTEASE INHIBITORS; HIV-1 REVERSE TRANSCRIPTASE; HUMANS; MICROBIAL SENSITIVITY TESTS; MUTATION; REVERSE TRANSCRIPTASE INHIBITORS; RNA, VIRAL; VIRAL LOAD; VIRUS REPLICATION;

EID: 3042836927     PISSN: 1570162X     EISSN: None     Source Type: Journal    
DOI: 10.2174/1570162043351192     Document Type: Review

References (65)

1. Ait-Khaled M, Rakik A, Griffin P, Cutrell A, Fischl MA, Clumeck N, Greenberg SB, Rubio R, Peters BS, Pulido F, Gould J, Pearce G, Spreen W, Tisdale M, Lafon S; CNA3003 International Study Team. (2002). Antiviral Therapy. 7 :43-51.
2. Ait-Khaled M, Stone C, Amphlett G, Clotet B, Staszewski S, Katlama C, Tisdale M, on behalf of the CNA3002 (2002). AIDS. 16: 1686-1689.
3. Antinori A, Zaccarelli M, Cingolani A, Forbici F, Rizzo MG, Trotta MP, Di Giambenedetto S, Narciso P, Ammassari A, Girardi E, De Luca A, Perno CF. (2002). AIDS Research and Human Retroviruses. 18(12): 835-8.
4. Bacheler LT, Anton ED, Kudish P, Baker D, Bunville J, Krakowski K, Bolling L, Aujay M, Wang XV, Ellis D, Becker MF, Lasut AL, George HJ, Spalding DR, Hollis G, Abremski K. (2000). Antimicrobial Agents Chemotherapy. 44(9): 2475-84.
5. Birk M, Svedhem V, Sonnerborg A. (2001). AIDS. 27;15(11): 1359-68.
6. Byrnes VW, Emini EA, Schleif WA, Condra JH, Schneider CL, Long WJ, Wolfgang JA, Graham DJ, Gotlib L, Schlabach AJ. (1994). Antimicrobial Agents Chemotherapy. 38: 1404-7.
7. Boucher CA, Cammack N, Schipper P, Schuurman R, Rouse P, Wainberg MA, Cameron JM. (1993). Antimicrobial Agents Chemotherapy. 37: 2231-4.
8. Caesar Trial. (1997). Lancet. 349: 1413-21.
9. Ciancio BC, Trotta MP, Lorenzini P, Forbici F, Visco-Comandini U, Gori C, Bonfigli S, Bellocchi MC, Sette P, D'Arrigo R, Tozzi V, Zaccarelli M, Boumis E, Narciso P, Perno CF, Antinori A. (2003). Antiviral Therapy. 8: 611-6.
10. Collins JA, Thompson MG, Paintsil E, Ricketts M, Gedzior J, Alexander L. (2004). Journal of Virology. 78(2): 603-11.
11. Deeks SG. (2001). Journal of Acquired Immune Deficiency Syndromes. 26 Suppl 1: S25-33.
12. Devereux HL, Emery VC, Johnson MA, Loveday C. (2001). Journal of Medical Virology. 65(2): 218-24.
13. Diallo K, Marchand B, Wei X, Cellai L, Gotte M, Wainberg MA. (2003). Journal of Virology. 77(16): 8621-32.
14. Dueweke TJ, Pushkarskaya T, Poppe SM, Swaney SM, Zhao JQ, Chen IS, Stevenson M, Tarpley WG. (1993). Proceedings of the National Academy of Sciences of the United States of America. 90(10): 4713-7.
15. Dykes C, Fox K, Lloyd A, Chiulli M, Morse E, Demeter LM. (2001). Virology. 5;285(2): 193-203.
16. Eshleman SH, Guay LA, Mwatha A, Brown ER, Cunningham SP, Musoke P, Mmiro F, Jackson JB. (2004). Journal of Acquired Immune Deficiency Syndromes. 35(2): 126-30.
17. Eshleman SH, Mracna M, Guay LA, Deseyve M, Cunningham S, Mirochnick M, Musoke P, Fleming T, Glenn Fowler M, Mofenson LM, Mmiro F, Jackson JB. (2001): AIDS. 15(15): 1951-7.
18. Gandhi RT, Wurcel A, Rosenberg ES, Johnston MN, Hellmann N, Bates M, Hirsch MS, Walker BD. (2003). Clinical Infectious Diseases. 37(12): 1693-8.
19. Hammer SM, Vaida F, Bennett KK, Holohan MK, Sheiner L, Eron JJ, Wheat LJ, Mitsuyasu RT, Gulick RM, Valentine FT, Aberg JA, Rogers MD, Karol CN, Saah AJ, Lewis RH, Bessen LJ, Brosgart C, DeGruttola V, Mellors JW, AIDS Clinical Trials Group 398 Study Team. (2002). JAMA. 288: 169-80.
20. Hanna GJ, Johnson VA, Kuritzkes DR, Richman DD, Brown AJ, Savara AV, Hazelwood JD, D'Aquila RT. (2000). Journal of Infectious Diseases. 181(3): 904-11.
21. Haubrich RH, Kemper CA, Hellmann NS, Keiser PH, Witt MD, Forthal DN, Leedom J, Leibowitz M, Whitcomb JM, Richman D, McCutchan JA and the California Collaborative Group. (2002). AIDS. 16: 33-40.
22. Havlir DV, Hellmann NS, Petropoulos CJ, Whitcomb JM, Collier AC, Hirsch MS, Tebas P, Sommadossi JP, Richman DD. (2000). JAMA. 283(2): 229-34.
23. Hirsch MS, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, Demeter LM, Hammer SM, Johnson VA, Loveday C, Mellors JW, Jacobsen DM, Richman DD. (2003). Clinical Infectious Diseases. 37(1): 113-28.
24. Ho DD, Neumann AU, Perelson AS, Chen W, Leonard JM, Markowitz M. (1995). Nature. 373: 123-6.
25. Iglesias-Ussel MD, Casado C, Yuste E, Olivares I, Lopez-Galindez C. (2002). Journal of General Virology. 83(Pt 1): 93-101.
26. Joly V, Descamps D, Peytavin G, Touati F, Mentre F, Duval X, Delarue S, Yeni P, Brun-Vezinet F. (2004). Antimicrobial Agents Chemotherapy. 48(1): 172-5.
27. Kavlick MF, Shirasaka T, Kojima E, Pluda JMH Jr, Yarchoan R, Mitsuya H. (1995). Antiviral Resistance. 28: 133-46.
28. Katzenstein DA, Bosch RJ, Hellmann N, Wang N, Bacheler L, Albrecht MA, ACTG 364 Study Team. (2003). AIDS. 17: 821-830.
29. Kempf DJ, King MS, Bernstein B, Cernohous P, Bauer E, Moseley J, Gu K, Hsu A, Brun S, Sun E. (2004). Journal of Infectious Diseases. 189(1): 51-60.
30. Kuritzkes DR, Shugarts D, Bakhtiari M, Poticha D, Johnson J, Rubin M, Gingeras TR, Kennedy M, Eron JJ. (2000). Journal of Acquired Immune Deficiency Syndromes. 23: 26-34.
31. Larder BA. (1002). Antimicrobial Agents Chemotherapy. 36: 2664-9.
32. Larder BA, Kemp SD, Harrigan PR. (1995). Science. 269: 696-699.
33. Leigh Brown AJ, Frost SD, Good B, Daar ES, Simon V, Markowitz M, Collier AC, Connick E, Conway B, Margolick JB, Routy JP, Corbeil J, Hellmann NS, Richman DD, Little SJ. (2004). Journal of Virology. 78: 2242-2246.
34. Lu J, Sista P, Giguel F, Greenberg M, Kuritzkes DR. (2004). Journal of Virology. 78(9): 4628-37.
35. Lucas JM, Chaisson RE, Moore RD. (1999). Annals of Internal Medicine. 131: 81-87.
36. Maeda Y, Venzon DJ, Mitsuya H. (1998). Journal of Infectious Diseases. 177: 1207-13.
37. Matsumi S, Kosalaraksa P, Tsang H, Kavlick MF, Harada S, Mitsuya H. (2003). AIDS. 17: 1127-37.
38. Miller MD, Anton KE, Mulato AS, Lamy PD, Cherrington JM. (1999). Journal of Infectious Diseases. 179: 92-100.
39. Miller MD, Margot N, Lu B, Zhong L, Chen SS, Cheng A, Wulfsohn M. (2004). Journal of Infectious Diseases. 189(5): 837-46.
40. Miller V, Sturmer M, Staszewski S, Groschel B, Hertogs K, De Bethune MP, Pauwels R, Harrigan PR, Bloor S, Kemp SD, Larder BA. (1998). AIDS. 12: 705-12.
41. Mocroft A, Devereux H, Kinloch-de-Loes S, Wilson D, Madge S, Youle M, Tyrer M, Loveday C, Phillips AN, Johnson MA. (2000). AIDS. 14: 1545-52.
42. Mouroux M, Descamps D, Izopet J, Yvon A, Delaugerre C, Matheron S, Coutellier A, Valantin MA, Bonmarchand M, Agut H, Massip P, Costagliola D, Katlama C, Brun-Vezinet F, Calvez V. (2001). Antiviral Therapy. 6: 179-83.
43. Nijhuis M, Schuurman R, de Jong D, Erickson J, Gustchina E, Albert J, Schipper P, Gulnik S, Boucher CA. (1999). AIDS. 13: 2349-59.
44. Nijhuis M, Schuurman R, de Jong D, Van Leeuwen R, Lange J, Danner S, Keulen W, De Groot T, Boucher CA. (1997). Journal of Infectious Diseases. 176: 398-405.
45. Perelson AS, Neumann AU, Markowitz M, Leonard JM, Ho DD. (1996). Science. 271: 1582-6.
46. Petrella M, Wainberg MA. (2002). AIDS Review. 4: 224-32.
47. Quinones-Mateu ME, Tadele M, Parera M, Mas A, Weber J, Rangel HR, Chakraborty B, Clotet B, Domingo E, Menendez-Arias L, Martinez MA. (2002). Journal of Virology. 76: 10546-52.
48. Picchio GR, Valdez H, Sabbe R, Landay AL, Kuritzkes DR, Lederman MM, Mosier DE. (2000). Journal of Acquired Immune Deficiency Syndromes. 25(4): 289-95.
49. Richman DD, Havlir D, Corbeil J, Looney D, Ignacio C, Spector SA, Sullivan J, Cheeseman S, Barringer K, Pauletti D. (1994). Journal of Virology. 68: 1660-1666.
50. Roge BT, Katzenstein TL, Obel N, Nielsen H, Kirk O, Pedersen C, Mathiesen L, Lundgren J, Gerstoft J. (2003). Antiviral Therapy. 8(2): 173-82.
51. Shulman N, Zolopa AR, Passaro D, Shafer RW, Huang W, Katzenstein D, Israelski DM, Hellmann N, Petropoulos C, Whitcomb J. (2001). AIDS. 15: 1125-1132.
52. St Clair MH, Martin JL, Tudor-Williams G, Bach MC, Vavro CL, King DM, Kellam P, Kemp SD, Larder BA. (1991). Science. 253: 1557-9.
53. Sune C, Brennan L, Stover DR, Klimkait T. (2004). Clinical Microbiology & Infection. 10(2): 119-26.
54. Tisdale M, Alnadaf T, Cousens D. (1997). Antimicrobial Agents Chemotherapy. 41: 1094-8.
55. Tisdale M, Kemp SD, Parry NR, Larder BA. (1993). Proceedings of the National Academy of Sciences of the United States of America. 90: 5653-5656.
56. Tozzi V, Zaccarelli M, Narciso P, Maria Trotta MP, Ceccherini-Silberstein F, De Longis P, D'Offizi G, Forbici F, D'Arrigo R, Boumis E, Bellagamba R, Bonfigli S, Carvelli C, Antinori A, Perno CF. (2004). Journal of Infectious Diseases. 189(9): 1688-95.
57. Van Rompay KK, Matthews TB, Higgins J, Canfield DR, Tarara RP, Wainberg MA, Schinazi RF, Pedersen NC, North TW. (2002). Journal of Virology. 76(12): 6083-92.
58. Wainberg MA, Drosopoulos WC, Salomon H, Hsu M, Borkow G, Parniak M, Gu Z, Song Q, Manne J, Islam S, Castriota G, Prasad VR. (1996). Science. 271: 1282-5.
59. Weber J, Rangel HR, Chakraborty B, Marotta ML, Valdez H, Fransen K, Florence E, Connick E, Smith KY, Colebunders RL, Landay A, Kuritzkes DR, Lederman MM, Vanham G, Quinones-Mateu ME. (2003). Journal of Acquired Immune Deficiency Syndromes. 33(4): 448-460.
60. Wei X, Liang C, Gotte M, Wainberg MA. (2003). Virology. 311(1): 202-12.
61. Whitcomb JM, Huang W, Limoli K, Paxinos E, Wrin T, Skowron G, Deeks SG, Bates M, Hellmann NS, Petropoulos CJ. (2002). AIDS. 16: 41-47.
62. White KL, Margot NA, Wrin T, Petropoulos CJ, Miller MD, Naeger LK. (2002). Antimicrobial Agents Chemotherapy. 46(11): 3437-46.
63. Zaccarelli M, Perno CF, Forbici F, Cingolani A, Liuzzi G, Bertoli A, Trotta MP, Bellocchi MC, Di Giambenedetto S, Tozzi V, Gori C, D'Arrigo R, De Longis P, Noto P, Girardi E, De Luca A, Antinori A. (2003). Antiviral Therapy. 8(1): 51-6.
64. Zaccarelli M, Perno CF, Forbici F, Soldani F, Bonfigli S, Gori C, Trotta MP, Bellocchi MC, Liuzzi G, D'Arrigo R, De Longis P, Boumis E, Bellagamba R, Tozzi V, Narciso P, Antinori A. (2004). Clinical Infectious Diseases. 38(3): 433-7.
65. Zachary KC, Hanna GJ, D'Aquila RT. (2001). Clinical Infectious Diseases. 33: 2075-7.